Efficacy and Safety of Depemokimab Monotherapy Without Concomitant Use of Intranasal Corticosteroids (INCS) in Japanese Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
NCT07701967
·
clinicaltrials.gov ↗
PHASE4
Phase
RECRUITING
Status
28
Enrollment
INDUSTRY
Sponsor class
Conditions
Nasal Polyps
Interventions
BIOLOGICAL:
Depemokimab
Sponsor
GlaxoSmithKline